Molly S C Li - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Molly S C Li

Showing results (1-10 of 25) with videos related to

Pageof 3

Sort By:

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 9, 2025

Distant Cousins From the Same Family-Understanding Uncommon EGFR MutationsStephanie P L Saw, Molly S C Li

The Lancet. Respiratory Medicine|August 19, 2024

Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON studyMolly S C Li, Stephanie P L Saw, Alfredo Addeo

Journal of Thoracic Disease|March 12, 2026

Optimal duration of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a systematic review and meta-analysisZelong Chen, Molly S C Li, W K Jacky Lam

Cancer Innovation|June 8, 2026

Practice-Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025Zhenyu Zhou, Wanting Gao, Molly S C Li, et al.

Annals of Translational Medicine|September 7, 2023

Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative reviewMolly S C Li, Kevin K S Mok, Tony S K Mok

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2020

Have We Revealed the Achilles' Heel of Brigatinib? Implications on Clinical PracticeHerbert H Loong, Molly S C Li, Gordon C H Tang, et al.

The Journal of Liquid Biopsy|March 3, 2025

Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectivesMolly S C Li, Kevin K S Mok, Landon L Chan, et al.

Clinical Epigenetics|March 2, 2023

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interferenceLok Seng Chan, Johnson Liu, Molly S C Li, et al.

Therapeutic Advances in Medical Oncology|December 9, 2024

Next-generation immunotherapy: igniting new hope for lung cancerMolly S C Li, Andrew L S Chan, Kevin K S Mok, et al.

Clinical Lung Cancer|July 28, 2024

Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence RiskOlivia H Chen, Wesley K Y Wong, Kevin K S Mok, et al.

Pageof 3

Search research articles

Showing results (1-10 of 25) with videos related to

Sort By:

Pageof 3

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 9, 2025

Distant Cousins From the Same Family-Understanding Uncommon EGFR MutationsStephanie P L Saw, Molly S C Li

The Lancet. Respiratory Medicine|August 19, 2024

Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON studyMolly S C Li, Stephanie P L Saw, Alfredo Addeo

Journal of Thoracic Disease|March 12, 2026

Optimal duration of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a systematic review and meta-analysisZelong Chen, Molly S C Li, W K Jacky Lam

Cancer Innovation|June 8, 2026

Practice-Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025Zhenyu Zhou, Wanting Gao, Molly S C Li, et al.

Annals of Translational Medicine|September 7, 2023

Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative reviewMolly S C Li, Kevin K S Mok, Tony S K Mok

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2020

Have We Revealed the Achilles' Heel of Brigatinib? Implications on Clinical PracticeHerbert H Loong, Molly S C Li, Gordon C H Tang, et al.

The Journal of Liquid Biopsy|March 3, 2025

Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectivesMolly S C Li, Kevin K S Mok, Landon L Chan, et al.

Clinical Epigenetics|March 2, 2023

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interferenceLok Seng Chan, Johnson Liu, Molly S C Li, et al.

Therapeutic Advances in Medical Oncology|December 9, 2024

Next-generation immunotherapy: igniting new hope for lung cancerMolly S C Li, Andrew L S Chan, Kevin K S Mok, et al.

Clinical Lung Cancer|July 28, 2024

Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence RiskOlivia H Chen, Wesley K Y Wong, Kevin K S Mok, et al.

Pageof 3